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Collision-induced dissociation of singly charged peptide ions produced by resonant excitation
in a matrix-assisted laser desorption/ionization (MALDI) ion trap mass spectrometer yields
relatively low complexity MS/MS spectra that exhibit highly preferential fragmentation,
typically occurring adjacent to aspartyl, glutamyl, and prolyl residues. Although these spectra
have proven to be of considerable utility for database-driven protein identification, they have
generally been considered to contain insufficient information to be useful for extensive de
novo sequencing. Here, we report a procedure for de novo sequencing of peptides that uses
MS/MS data generated by an in-house assembled MALDI-quadrupole-ion trap mass spec-
trometer (Krutchinsky, Kalkum, and Chait Anal. Chem. 2001, 73, 5066–5077). Peptide sequences
of up 14 amino acid residues in length have been deduced from digests of proteins separated
by SDS-PAGE. Key to the success of the current procedure is an ability to obtain MS/MS
spectra with high signal-to-noise ratios and to efficiently detect relatively low abundance
fragment ions that result from the less favorable fragmentation pathways. The high signal-to-
noise ratio yields sufficiently accurate mass differences to allow unambiguous amino acid
sequence assignments (with a few exceptions), and the efficient detection of low abundance
fragment ions allows continuous reads through moderately long stretches of sequence. Finally,
we show how the aforementioned preferential cleavage property of singly charged ions can be
used to facilitate the de novo sequencing process. (J Am Soc Mass Spectrom 2003, 14,
1012–1021) © 2003 American Society for Mass Spectrometry
The use of mass spectrometry combined withdatabase searching has gained wide acceptancefor rapid, sensitive protein identification [1]. This
method requires the availability of extensive protein,
cDNA, or genomic sequence from the organism of
interest (or at least from a closely related species). If
such sequence information is not available, as remains
the case for the vast majority of extant organisms, it is
desirable to utilize de novo peptide sequencing to
identify and obtain information about their protein(s).
Although Edman sequencing has for a long time been a
method of choice for de novo sequencing of peptides
and proteins, mass spectrometry (MS) has also been
shown to have considerable utility for this purpose.
Indeed, mass spectrometric de novo sequencing
based on the fragmentation of derivitized peptide ions
dates back to the late 1960s and on underivatized
peptide ions to the early 1980s (reviewed in [2] and [3]).
More recently, MS sequencing has been given consid-
erable impetus by the development of ESI and MALDI,
ionization techniques whose efficiencies for producing
intact peptide ions are far higher than those that were
previously available. Again, both derivitized and un-
derivatized peptides have been used in this newer
work. Thus, chemical derivatization has been applied to
simplify/enhance the fragmentation spectra and/or to
differentiate N- from C-terminal fragment ions [4–13].
Notable in this regard is the use of 18O incorporation at
the carboxyl-termini of peptides during protein hydro-
lysis [14–17]. For underivatized peptides, ESI has found
use for de novo sequencing under a variety of condi-
tions, which include collision-induced dissociation
(CID) in the triple quadrupole mass analyzer [18–20]
and the QqTOF mass analyzer [18, 19, 21–26], resonant
excitation in the quadrupole ion trap mass analyzer [14,
27–29], and electron capture dissociation in the Fourier
transform ion cyclotron resonance mass analyzer [30–
34]. MALDI de novo sequencing has been carried out
using CID and metastable decay in single- [35] and
double-stage [36–39] TOF instruments and with CID in
QqTOF instruments [40–44]. A number of computer
algorithms have also been devised that seek to infer
sequence de novo from MS/MS data [45–50].
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In mass spectrometric de novo sequencing, the can-
didate peptide sequence is derived directly from its
MS/MS fragmentation spectrum. The accuracy of the
method depends on the accuracy with which the mass
differences between the relevant ion peaks are deter-
mined, the completeness of the observed fragment ion
series, and the extent to which the fragmentation spec-
trum can be correctly interpreted. The completeness of
the observed fragmentation series depends on the par-
ticular sequence of the peptide under study, the charge
state of the ion produced, and the mode by which the
fragmentation is induced within the mass spectrometer.
By and large, doubly charged peptide ions tend to
fragment more evenly across a given sequence than do
singly charged ion species ([40, 44, 51] and extensive
personal observations). Thus, a large proportion of de
novo sequencing has been performed on doubly
charged ions, which are readily produced from tryptic
peptides by electrospray ionization (ESI). By contrast,
MALDI produces predominantly singly charged ions
from peptides. These singly charged ion species often
yield relatively low complexity CID mass spectra that
tend to be dominated by a few preferred fragmentation
pathways [40, 52–56]. When this fragmentation is in-
duced on the slow time scale of resonant excitation
within an ion trap mass spectrometer, the dissociation
of singly-charged ions becomes especially selective,
occurring largely adjacent to any aspartyl, glutamyl, or
prolyl residues that may be present in the peptide [54,
56]. Although the resulting low complexity spectra have
proven to be of considerable utility for database-driven
protein identification [57–60], we have generally con-
sidered these spectra to contain insufficient information
to be useful for extensive de novo sequence determina-
tion.
MALDI ionization has several attractive properties
for the analysis of peptides. It has a relatively high
tolerance to impurities and common biochemical addi-
tives and salts, reducing the demands on sample prep-
aration compared to that required for ESI. In addition,
the MALDI sample is reusable until it is depleted. Thus,
provided that the instrument used for mass analysis has
sufficient sensitivity, data can be collected from many
different ions species produced from a single peptide
mixture and this data can be collected until the desired
quality of spectra have been obtained. Towards these
goals, we recently assembled a MALDI-ion trap mass
spectrometer by adding a MALDI source and a quad-
rupole interface to a commercial ion trap mass analyzer
(Finnigan Thermoquest LCQ DECA XP, San Jose, CA)
[59, 61]. This configuration has proved sufficiently
efficient to allow us to detect ions resulting from
relatively low probability cleavage pathways and to
observe more complete sets of fragment ion series than
we previously thought possible. Using this instrument,
we demonstrate that de novo sequencing is feasible
using resonant excitation of singly charged ions in an
ion trap and that the rules governing preferential cleav-
age can actually be helpful in the de novo sequencing
process.
Experimental
Sample preparation
The resolved protein band at 55 kDa on the Coomas-
sie stained SDS-PAGE of a sample derived from pine
tree (Xylem pinus) is estimated to contain 0.5 g (10
pmol) of protein based on visual comparison to the 1 g
BSA band (Figure 1), while the 60 kDa band from
cultured human HeLa cells is estimated to contain
50–100 ng (1–2 pmol) (Figure 5). These two bands were
excised and subjected to an in-gel digestion procedure
described elsewhere using between 0.1–0.2 g of tryp-
sin on each band [62]. The resulting peptide mixture
was extracted from the gel band as described [62] using
Poros 50 reversed phase beads (Perseptive Biosystems,
MA) and eluted with matrix solution (2 dilution of a
saturated solution of 2,5-dihydroxybenzoic acid in 60%
Methanol/5%acetic acid) onto a compact disc MALDI
sample probe [59, 61]. This compact disc MALDI sam-
ple probe was first loaded into the MALDI-QqTOF
mass spectrometer for peptide mapping and subse-
quently into the MALDI-quadrupole ion trap mass
spectrometer for MS/MS analysis. This ability to exam-
ine the same sample in both mass spectrometers allows
us to take advantage of the particular strengths of each
instrument—i.e., the high mass determination accuracy
of the MALDI-QqTOF mass spectrometer and the high
efficiency for obtaining product ion mass spectra of the
MALDI-quadrupole ion trap mass spectrometer. Thus,
we use the first to obtain peptide maps with high mass
accuracy, and subsequently obtain product ion spectra
on any or all of the individual peptide ions observed in
the peptide map.
MALDI QqTOF Mass Spectrometer
Peptide map spectra were collected on an in-house
modified MALDI-QqTOF (Centaur, Sciex, Concord,
ON) instrument [62]. The nitrogen laser (VSL-337, Laser
Figure 1. Portion of SDS-PAGE gel of proteins isolated from pine
tree (Xylem pinus) visualized with Coomassie blue stain (right
lane). The 55 kDa protein band indicated by the arrow was
subjected to in-gel digestion with trypsin, and several of the
resulting peptides (see Figure 2) were subjected to de novo
sequencing. One microgram of BSA was loaded in the left lane as
a standard.
1013J Am Soc Mass Spectrom 2003, 14, 1012–1021 “DE NOVO” PEPTIDE SEQUENCING BY MALDI
Science Inc., Spectra-Physics, Franklin, MA) was oper-
ated at 30 Hz. This instrument was modified to accept a
MALDI compact disc (CD) target [59, 61] so that the CD
target is readily exchangeable between the MALDI-
QqTOF and MALDI-quadrupole ion trap instruments.
MALDI-Quadrupole Ion Trap Mass Spectrometer
Collission-induced fragmentation spectra were col-
lected on a MALDI-quadrupole ion trap mass spec-
trometer, which we recently assembled by adding an
in-house built MALDI source and a quadrupole inter-
face to a LCQ DECA XP (Finnigan Thermoquest) ion
trap mass spectrometer [59, 61]. The nitrogen laser
(VSL-337, Laser Science Inc, MA) was operated at 20
Hz.
Product Ion Experiments
All product ion spectra were obtained using the follow-
ing settings of the LCQ DECA XP: automatic gain
control (AGC) off, ion injection time 500 ms, m/z win-
dow 4 (“isolation width”), excitation energy 30% (“nor-
malized collision energy”), q of excitation 0.25 (“activa-
tion q”) and excitation time 300 ms (“activation time”).
The ion count displayed on the “Tune Plus” window
was in the range 8  105–3  106. The number of
microscans for the collection of product ion spectra
ranged from 60–150 (collection times between 1–2.5
min). The averaged spectra were displayed in the “Tune
Plus” window during data acquisition to allow us to
assess the quality of the spectra during collection and to
judge when to stop acquisition.
Data Analysis
De novo sequencing was performed manually. After
obtaining the product ion spectrum, we first inspected
the low mass region to visually identify peaks with
good signal-to-noise ratio. Assuming that each peak
corresponds to a y-ion (or b-ion) fragment, we look for
its complimentary b-ion (or y-ion) by subtracting the
m/z value of the fragment ion from the m/z value of the
singly protonated parent ion and adding a hydrogen
mass. If the complementary ion exists in the spectrum,
we mark the pair on the spectrum. Then, we inspect the
whole spectrum to identify other major peaks and look
for their complementary fragment ions and mark the
pairs. Thus the spectrum in the region from the low
mass cut-off to the parent mass minus the low-cut mass
cutoff is greatly simplified. De novo sequencing is
performed starting with these marked complementary
pairs.
To assess the accuracy of our de novo sequencing
results, the product ion spectra were converted to the
“dta format” and submitted to the Mascot search engine
(Matrix Science Ltd., London, UK) to search the NCBI
EST database. For sequences that were not identified
using the search engine (because of unanticipated cleav-
ages), we searched the databases directly with the de
novo-determined sequences.
Results and Discussion
We began the present de novo sequencing investigation
during a study of proteins from the pine tree (Xylem
pinus) at a time when relatively few full-length pine
protein sequences were available and when we were
unable to gain access to the pine EST database. Subse-
quent access to this database allowed us to objectively
assess the accuracy of our de novo sequencing efforts
using the same tandem mass spectrometric data and
conventional database searches.
The example, which we will discuss in detail, in-
volves sequence from the 55 kDa protein band shown in
Figure 1, which we estimate to contain 0.5 g (10
pmol) of protein. Figure 2 shows the MALDI-QqTOF
peptide map obtained following in-gel tryptic digestion
of the 55 kDa band. Because our in-house assembled
MALDI-quadrupole-ion trap mass spectrometer is sen-
sitive and efficient, we speculated that it might be
feasible to detect the less abundant fragment ions
resulting from the less favorable peptide bond cleav-
ages. We therefore attempted de novo peptide sequenc-
ing by collecting product ion spectra with high signal-
to-noise for the seven strongest peaks in the spectrum.
We used spectral accumulation times that were 10–25
times longer than those that we normally use for
protein identification by regular database searching.
Thus we used collection times of 1–2.5 min rather than
the 5–7 s used for database searching.
Figure 3 shows a product ion spectrum of the parent
ion with m/z 1705.882 (accumulation time 60 s). The
large amount of sample (10 pmol) and the longer than
normal spectral accumulation time yielded a spectrum
with high signal-to-noise ratio, enabling detection of
fragment ions originating from cleavage at every pep-
tide bond. To simplify spectral interpretation, we iden-
tified complementary b- and y-ions in the low mass
region of the spectrum using the procedure described
under the heading Data Analysis. We then started to
build sequence using these complementary ions and
extended the sequence into the high mass region where
complementary ion information is unavailable. In this
way, two long b- and y-ion series were identified. The
sequences derived from the b- and y-ion series overlap
over a stretch of four amino acid residues. In this way,
the peptide was manually sequenced to be VVDEE[I/
L]FD[I/L][I/L]E[Q/K]EK, where [I/L] denotes either I
or L and [Q/K] either Q or K. Note that the high
signal-to-noise has made relatively weak peaks in Fig-
ure 3 clearly visible. These weak peaks correspond to y
or b fragment ions without which de novo sequencing
would be impossible. The high signal-to-noise also
allowed us to determine the mass difference between
adjacent pairs of fragment ion peaks with accuracy
generally better than 0.1 Da (Figure 3), further facilitat-
ing the de novo sequencing process. Finally, we found
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that previously described rules governing preferential
fragmentation [54, 56] can be useful in assessing the
plausibility of the amino acid assignment and the
assignment of ion series to which an intense ion peak
belongs. For example, the strong peak at 759.59 Da is
consistent with the assignment that it is a y-ion frag-
ment resulted from a preferential cleavage between the
peptide bond D[I/L]. The strong peak at 1559.85 Da is a
b-ion fragment from a preferential cleavage between the
peptide bond EK. Thus, the preferential cleavage prop-
erty of MALDI ion in the ion trap can be useful in
distinguishing y-ion and b-ion series. After obtaining
Figure 2. MALDI-QqTOF tryptic peptide mass map of the 55 kDa pine protein band shown in Figure
1. The seven peaks labeled with bold face were selected for MALDI-quadrupole ion trap tandem mass
spectrometry. The label “De novo only” indicates that the labeled peptide was identified by de novo
sequencing, but not by the EST database search. The label “EST only” indicates that the labeled
peptide was identified by the EST database search, but not by de novo sequencing. The label “De novo
and EST” indicates that the labeled peptide was identified by both de novo sequencing and EST
database searching.
Figure 3. MALDI-quadrupole ion trap product ion mass spectrum of the m/z 1705.882 ion from the
55 kDa pine protein band digest (Figure 2). The numbers within the brackets provide differences
between the experimental and theoretical masses of the assigned amino acids.
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the de novo sequence, the EST database became avail-
able. We thus searched this database with the same
tandem mass spectrometric data, using the Mascot
search engine. The EST database search yielded the
sequence VVDEEIFDLIEKEK, which with the exception
of certain ambiguities (discussed below), matches and
confirms our de novo sequencing result.
Table 1 summarizes our de novo sequencing results
on the peptides indicated in Figure 2 together with the
subsequently obtained EST database search results. Out
of the seven product ion spectra investigated, de novo
sequencing yielded entire or nearly entire sequences for
the six peptides (1, 2, 3, 5, 6, 7 in Table 1) and did not
yield sequence for one of the peptides (4 in Table 1). EST
database searching also identified six peptides, but
missed peptide 1 (Table 1). Note that a different peptide
was missed by each technique and that the de novo
sequencing and EST database search results overlap for
five of the seven peptides. The de novo-deduced se-
quences are consistent with those identified in the EST
database, with the exception of certain ambiguities and
two incorrect assignments. In addition to the well
known isobaric I/L ambiguity, the mass accuracy of the
ion trap mass spectrometer is not sufficiently high to
distinguish between K and Q and between the N-
terminal amino acid pairs (AL)/(SP) for the peptide at
m/z 1258.649 and (VV)/(PT) for the peptide at m/z
1448.756. Ambiguities among these pairs of amino acids
are caused by the absence of an observable yn1 ion
fragment peak corresponding to loss of the N-terminal
amino acid residue. Certain of these non-isobaric ambi-
guities can be resolved by determining the peptide
masses with high accuracy. Thus, we were able to
resolve the ambiguity between Q and K at residue 12 of
peptide 6 through examination of the mass of the
peptide determined in the MALDI-QqTOF measure-
ment (Figure 2). For example, the m/z of the 1705.882
peptide was determined with an accuracy of5 ppm. If
one assumes that residue 12 of this peptide is Q, the
theoretical mass differs from the experimental mass by
17 ppm, whereas the difference is only 4 ppm if we
assume that residue 12 is K. Resolution of this ambigu-
ity allows us to deduce the sequence VVDEE[I/L]FD[I/
L][I/L]EKEK, again in agreement with that deduced
from the EST search. In a similar manner, we were able
to resolve the ambiguity between the pair VV and PT in
peptide 3 because the sequence with VV agrees with the
experimental mass to within 3 ppm whereas the se-
quence with PT differs by 24 ppm. However, in those
cases where we find more than one non-isobaric ambi-
guity (i.e., peptides 5 and 7), the accurate mass may not
help resolve the ambiguities.
One apparent error in our de novo sequence for the
peptide with m/z 1640.777 (peptide 5) was the assign-
ment of the single amino acid residue Q (or K) in place
of the two amino acid residues, GA, deduced from the
EST database. We can trace the origin of this error to the
fact that we missed the small peak that corresponds to
cleavage between the G and A peptide bond, a reaction
pathway that we have previously reported to occur
with relatively low probability [63] .
In some cases, knowledge of the fragmentation sys-
tematics of singly charged ions can be used to assist in
the resolution of ambiguities. For example, in extensive
unreported work, we have observed that a proline
residue in the second position from the amino terminus
invariably results in an intense yn2 fragment. Note that
this preferred fragmentation pathway on the C-terminal
side of a P residue is specific to this second position (P
residues elsewhere result in preferred fragmentation on
the N-terminal side of P [53, 56]). In this case, failure to
observe an intense yn2 fragment indicates that the
terminal residues are likely AL or LA rather than SP
(we can rule out PS because trypsin only cleaves [K/R]P
sequences with very low efficiency.) Once this ambigu-
ity was partially resolved, it proved possible to resolve
the remaining Q/K ambiguity at the 3rd position since
Q yields a peptide mass that agrees to within 5 ppm and
K one that differs by 24 ppm.
Because of the frequent absence of the yn1 ion in the
spectrum (Table 1) and our inability to detect the low
mass b1 residue, determination of the N-terminal resi-
dues can present a special challenge. This is illustrated
by our mis-assignment of the N-terminal residues of
peptide 7, where we assigned [Q/K]W in place of VSQ
(as in the EST-derived sequence). We can trace this error
to the fact that while no yn1 fragment ion was in fact
observed (corresponding to the loss of the N-terminal V
residue), an intense peak was seen that was incorrectly
interpreted to arise from the loss of Q/K at the N-
terminal. In retrospect, we can see that the ion in
question arose from elimination of a K residue at the
C-terminus. Indeed, we frequently observe an intense
Table 1. Peptides identified by de novo sequencing and EST database searching
Peptide m/z (Da) De novo sequencing EST database
1 1224.672 PVNVWGNTPLK PVNVWGNTPLKa
2 1258.649 [(AL)/(SP)][Q/K]AFH[I/L]DSEK ALQAFHLDSEK
3 1448.756 [(VV)/(PT)]DEE[I/L]FD[I/L][I/L]EK VVDEEIFDLIEK
4 1618.830 No available ISATSIYFESLPYK
5 1640.777 [Q/K]G[Q/K]PE[Q/K]LYDYEDR KGQPEGALYDYEDR
6 1705.882 VVDEE[I/L]FD[I/L][I/L]E[Q/K]EK VVDEEIFDLIEKEK
7 1900.920 [Q/K]WETGF[I/L]DYD[Q/K][I/L]EEK VSQETGFIDYDKLEEK
aThe sequence of this non-tryptic peptide can be mapped to an existing EST, but was not identified by EST database searching (see text).
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loss of 128 Da (or 156 Da), which is formally equivalent
to hydrolysis of the terminal K residue (or R residue).
The case of peptide 4 (Table 1) illustrates the kind of
complication that can hinder de novo sequencing. Al-
though we were able to correctly deduce the partial
sequence YFESL (or LSEFY), we were unable to extend
this sequence any further because the next critical y-ion
fragment (y9) between I and S at m/z 1159.60 was hidden
in the middle of the isotopic pattern of a strong ion
fragment at m/z 1158.61, which appears to arise by the
loss of three water molecules from the b11 ion fragment
(m/z 1212.67) occurring between L and P (data not
shown).
Full-length de novo sequencing requires the obser-
vation of fragment ions from every peptide bond along
the peptide backbone. Despite the presence of factors
that cause ambiguities, we have found that product ion
spectra from the MALDI-quadruple ion trap can often
be used for de novo sequencing. In addition to obtained
five sequences that partially match those obtained from
EST database searches, this utility was convincingly
demonstrated for peptide 1 (m/z 1224.672). This is a case
in which de novo sequencing succeeded where the EST
database search failed. As shown in Figure 4, the
peptide was sequenced to be PVNVWGNTPLK. (The
unassigned major peaks are due to losses of ammonia/
water and the C-terminal elimination of the lysine
residue.) After we deduced this sequence, we used it to
search the contiguous EST sequence that we assembled
from our six MS/MS hits in the EST database. We found
that the peptide does indeed exist within the assembled
sequence, but that it is a non-tryptic peptide, which
explains why the search engine could not find it. Since
the EST sequence is . . .DPVNVWGNTPLK, we think it
likely that this non-tryptic peptide arose by cleavage of
the acid labile DP bond during extraction by acidic
solution (4% formic acid/0.06% TFA) of tryptic frag-
ments from the gel slice.
A practical issue in data acquisition is to collect as
many useful spectra for de novo sequencing as possible
from a single protein digest sample. Not every peak in
the spectrum of the resulting peptide mixture will result
in a useful product ion spectra because certain peptides
do not fragment in a manner that yields the needed
information. For these, it is preferable to discontinue
data collection so as not to waste sample. Conversely
for peptides that do produce informative product ion
spectra, we wish to spend an appropriate length of time
to collect sufficiently high signal-to-noise ratio data for
the small peaks. To determine when to continue collect-
ing data and when to stop, we display the averaged
spectrum during data acquisition and amplify the spec-
trum to inspect the small peaks. If the peaks are
sparsely distributed, we stop the acquisition. If the
peaks are distributed across the whole mass region, we
examine the weak peaks (normally in the low mass
region) and stop acquisition when a useable signal-to-
noise ratio has been achieved.
We have stated that more material is needed for
successful de novo sequencing in the MALDI-quadru-
pole ion trap compared to that required for protein
identification using product ion spectra database
searching. To get a better feeling for the minimum
quantity of material required for de novo sequencing,
we show a second example involving a 60 kDa human
protein where we estimate the amount of protein
Figure 4. MALDI-quadrupole ion trap product ion mass spectrum of the m/z 1224.672 ion from the
55 kDa pine protein band digest (Figure 2).
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present in the band of interest to be 50–100 ng (i.e., 1–2
pmol) (Figure 5). Conventional database searches using
tandem mass spectrometric data from several tryptic
peptides identify the protein MDM2 to be present in the
band. However, one of the peptides from the band
digest (having m/z 1859.848 as measured by QqTOF-
MS) did not map to any known tryptic peptide of
MDM2. Thus, we performed de novo sequencing on
this peptide. The procedure yielded the partial se-
quence 352QAEEGFDVPD361 (Figure 6), corresponding
to the C-terminal portion of a peptide from MDM2
(345AKLENSTQAEEGFDVPD361). This peptide appears
to originate from tryptic cleavage between K344 and
A345 and an unexpected cleavage between D361 and
C362. However, the theoretical m/z of this peptide is
1849.846, which is 10 Da lower than the measured m/z
(1859.848 as measured by QqTOF-MS). Assuming our
de novo C-terminal sequence to be correct, this discrep-
ancy should occur between residues 345–351. The sim-
plest explanation for this discrepancy is a single base
mutation that yields a P rather than an S residue at
position 350. This mutation yields the peptide 345AK-
LENPTQAEEGFDVPD361 with theoretical m/z 1859.858,
which is within 10 ppm of the measured value. Inspec-
tion of the tandem mass spectrum shown in Figure 6
appears to confirm this hypothesis since the expected
preferential cleavage on the N-terminal side of P350 is
observed, as is the partial sequence LEN. In this case,
we were able to use de novo sequencing to obtain partial
sequence of a mutant form of a peptide from MDM2 that
was cleaved in an unexpected position, and further to use
the MS/MS data to elucidate the nature of the mutation.
Figure 5. Portion of SDS-PAGE gel of proteins isolated from cultured human cells visualized with
Coomassie blue stain (left lane). The 60 kDa protein band indicated by the arrow was subjected to
in-gel digestion with trypsin, and one of the resulting peptides was subjected to de novo sequencing
(Figure 6). BSA (100 and 50 ng) was loaded onto the two right-hand lanes as standards.
Figure 6. MALDI-quadrupole ion trap product ion mass spectrum of the m/z 1859.848 ion from the
60 kDa human protein band digest.
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From the data provided above, we also conclude that
we currently need at least one order of magnitude more
material in the band of interest for de novo sequencing
than we normally require for conventional database-
driven protein identification.
Conclusion
We have demonstrated that tandem mass spectrometric
data generated in our in-house assembled MALDI-
quadrupole ion trap mass spectrometer can be used for
de novo sequencing of peptides from in-gel digested
proteins (although ambiguities and mis-assignments
are to be expected, especially for residues at the N-
terminal.) We have found that despite a proclivity to
fragment preferentially at certain amino acid residues,
singly charged MALDI ions within the ion trap can
fragment at nearly every peptide bond along the pep-
tide backbone. Given sufficient protein (1 pmol in the
gel), the highly sensitive MALDI-quadrupole ion trap
mass spectrometer is capable of detecting ions that
result from the less favorable fragmentation channels
with usable signal-to-noise ratios. The resulting tandem
mass spectra tend to be sufficiently simple to allow
straightforward de novo sequencing. Moreover, we
have found that the preferential cleavage of singly
charged ions can actually facilitate the de novo sequenc-
ing process.
Acknowledgments
This work was supported by a grant from the National Institutes
of Health (RR00862). The authors thank Drs. David Calhoun and
Ming Jin for the SDS-PAGE separated Xylem pinus proteins and
Drs. Wei Gu and Chris Brooks for the SDS-PAGE separated
human proteins, which were identified during our collaboration.
References
1. Mann, M.; Hendrickson, R. C.; Pandey, A. Analysis of Proteins
and Proteomes by Mass Spectrometry. Annu. Rev. Biochem.
2001, 70, 437–473.
2. Biemann, K.; Martin, S. A. Mass Spectrometric Determination
of the Amino Acid Sequence of Peptides and Proteins. Mass
Spectrom. Rev. 1987, 6, 1–76.
3. Papayannopoulos, I. A. The Interpretation of Collision-In-
duced Dissociation Tandem Mass Spectra of Peptides. Mass
Spectrom. Rev. 1995, 14, 49–73.
4. Keough, T.; Lacey, M. P.; Youngquist, R. S. Solid-Phase
Derivatization of Tryptic Peptides for Rapid Protein Identifi-
cation by Matrix-Assisted Laser Desorption/Ionization Mass
Spectrometry. Rapid Commun. Mass Spectrom. 2002, 16, 1003–
1015.
5. Keough, T.; Lacey, M. P.; Strife, R. J. Atmospheric Pressure
Matrix-Assisted Laser Desorption/Ionization Ion Trap Mass
Spectrometry of Sulfonic Acid Derivatized Tryptic Peptides.
Rapid Commun. Mass Spectrom. 2001, 15, 2227–2239.
6. Keough, T.; Lacey, M. P.; Youngquist, R. S. Derivatization
Procedures to Facilitate de Novo Sequencing of Lysine-Termi-
nated Tryptic Peptides Using Postsource Decay Matrix-As-
sisted Laser Desorption/Ionization Mass Spectrometry. Rapid
Commun. Mass Spectrom. 2000, 14, 2348–2356.
7. Keough, T.; Lacey, M. P.; Fieno, A. M.; Grant, R. A.; Sun, Y.;
Bauer, M. D.; Begley, K. B. Tandem mass spectrometry meth-
ods for definitive protein identification in proteomics research.
Electrophoresis 2000, 21, 2252–2265.
8. Bauer, M. D.; Sun, Y.; Keough, T.; Lacey, M. P. Sequencing of
Sulfonic Acid Derivatized Peptides by Electrospray Mass
Spectrometry. Rapid Commun. Mass Spectrom. 2000, 14, 924–
929.
9. Keough, T.; Youngquist, R. S.; Lacey, M. P. A Method for
High-Sensitivity Peptide Sequencing Using Postsource Decay
Matrix-Assisted Laser Desorption Ionization Mass Spectro-
metry. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 7131–7136.
10. Shen, T. L.; Huang, Z. H.; Laivenieks, M.; Zeikus, J. G.; Gage,
D. A.; Allison, J. Evaluation of Charge Derivatization of a
Proteolytic Protein Digest for Improved Mass Spectrometric
Analysis: De Novo Sequencing by Matrix-Assisted Laser De-
sorption/Ionization Post-Source Decay Mass Spectrometry. J.
Mass Spectrom. 1999, 34, 1154–1165.
11. Lindh, I.; Hjelmqvist, L.; Bergman, T.; Sjovall, J.; Griffiths, W. J.
De novo Sequencing of Proteolytic Peptides by a Combination
of C-terminal Derivatization and Nano-Electrospray/Colli-
sion-Induced Dissociation Mass Spectrometry. J. Am. Soc. Mass
Spectrom. 2000, 11, 673–686.
12. Muenchbach, M.; Quadroni, M.; Miotto, G.; James, P. Quanti-
tation and Facilitated de Novo Sequencing of Proteins by
Isotopic N-Terminal Labeling of Peptides with a Fragmenta-
tion-Directing Moiety. Anal. Chem. 2000, 72, 4047–4057.
13. Cagney, G.; Emili, A. De Novo Peptide Sequencing and
Quantitative Profiling of Complex Protein Mixtures Using
Mass-Coded Abundance Tagging. Nat. Biotechnol. 2002, 20,
163–170.
14. Qin, J.; Herring, C. J.; Zhang, X. De Novo Peptide Sequencing
in an Ion Trap Mass Spectrometer with 18O Labeling. Rapid
Commun. Mass Spectrom. 1998, 12, 209–216.
15. Wilm, M.; Neubauer, G.; Taylor, L.; Shevchenko, A.; Bachi, A.
De Novo Sequencing of Proteins with Mass Spectrometry
Using the Differential Scanning Technique. Proteome Prot.
Anal. 2000, 65–79.
16. Shevchenko, A.; Chernushevich, I.; Ens, W.; Standing, K. G.;
Thomson, B.; Wilm, M.; Mann, M. Rapid “De Novo” Peptide
Sequencing by a Combination of Nanoelectrospray, Isotopic
Labeling, and a Quadrupole/Time-of-Flight Mass Spectrome-
ter. Rapid Commun. Mass Spectrom. 1997, 11, 1015–1024.
17. Uttenweiler-Joseph, S.; Neubauer, G.; Christoforidis, S.; Zerial,
M.; Wilm, M. Automated De Novo Sequencing of Proteins
Using the Differential Scanning Technique. Proteomics 2001, 1,
668–682.
18. Shevchenko, A.; Chernushevich, I.; Shevchenko, A.; Wilm, M.;
Mann, M. “De Novo” Sequencing of Peptides Recovered from
In-Gel Digested Proteins by Nanoelectrospray Tandem Mass
Spectrometry. Mol. Biotechnol. 2002, 20, 107–118.
19. Shevchenko, A.; Chernushevich, I.; Wilm, M.; Mann, M. De
Novo Peptide Sequencing by Nanoelectrospray Tandem Mass
Spectrometry Using Triple Quadrupole and Quadrupole/
Time-of-Flight Instruments. Methods Mol. Biol. 2000, 146, 1–16.
20. Wilm, M.; Shevchenko, A.; Houthaeve, T.; Breit, S.; Schweig-
erer, L.; Fotsis, T.; Mann, M. Femtomole sequencing of pro-
teins from polyacrylamide gels by nano-electrospray mass
spectrometry. Nature 1996, 379, 466–469.
21. Morris, H. R.; Paxton, T.; Panico, M.; McDowell, R.; Dell, A. A
Novel Geometry Mass Spectrometer, the Q-TOF, for Low-
Femtomole/Attomole-Range Biopolymer Sequencing. J. Pro-
tein Chem. 1997, 16, 469–479.
22. Bateman, R. H.; Blackstock, W.; Bordoli, R. S.; Gilbert, A. J.;
Hoyes, J. B.; Langridge, J.; Ward, M. Protein Characterization
Using 2-D Gel Electrophoresis with Nanospray MS and
MS/MS on a Q-TOF. Adv. Mass Spectrom. 1998, 14.
1019J Am Soc Mass Spectrom 2003, 14, 1012–1021 “DE NOVO” PEPTIDE SEQUENCING BY MALDI
23. van Der Wel, H.; Morris, H. R.; Panico, M.; Paxton, T.; North,
S. J.; Dell, A.; Thomson, J. M.; West, C. M. A Non-Golgi
1,2-Fucosyltransferase that Modifies Skp1 in the Cytoplasm
of Dictyostelium. J. Biol. Chem. 2001, 276, 33952–33963.
24. Romaris, F.; North, S. J.; Gagliardo, L. F.; Butcher, B. A.;
Ghosh, K.; Beitin, D. P.; Panico, M.; Arasu, P.; Dell, A.; Morris,
H. R.; Appleton, J. A. A Putative Serine Protease Among the
Excretory-Secretory Glycoproteins of L1 Trichinella spiralis.
Mol. Biochem. Parasitol. 2002, 122, 149–160.
25. Vandenberghe, I.; Kim, J.-K.; Devreese, B.; Hacisalihoglu, A.;
Iwabuki, H.; Okajima, T.; Kuroda, S.; Adachi, O.; Jongejan,
J. A.; Duine, J. A.; Tanizawa, K.; Van Beeumen, J. The Covalent
Structure of the Small Subunit from Pseudomonas putida Amine
Dehydrogenase Reveals the Presence of Three Novel Types of
Internal Cross-Linkages, All Involving Cysteine in a Thioether
Bond. J. Biol. Chem. 2001, 276, 42923–42931.
26. Ou, K.; Seow, T. K.; Liang, R. C.; Ong, S. E.; Chung, M. C.
Proteome Analysis of a Human Heptocellular Carcinoma Cell
Line, HCC-M: An Update. Electrophoresis 2001, 22, 2804–2811.
27. Arnott, D.; Henzel, W. J.; Stults, J. T. Rapid Identification of
Comigrating Gel-Isolated Proteins by Ion Trap-Mass Spectro-
metry. Electrophoresis 1998, 19, 968–980.
28. Zhang, Z.; McElvain, J. S. De Novo Peptide Sequencing by
Two-Dimensional Fragment Correlation Mass Spectrometry.
Anal. Chem. 2000, 72, 2337–2350.
29. Sonsmann, G.; Romer, A.; Schomburg, D. Investigation of the
Influence of Charge Derivatization on the Fragmentation of
Multiply Protonated Peptides. J. Am. Soc. Mass Spectrom. 2002,
13, 47–58.
30. McLafferty, F. W.; Horn, D. M.; Breuker, K.; Ge, Y.; Lewis,
M. A.; Cerda, B.; Zubarev, R. A.; Carpenter, B. K. Electron
Capture Dissociation of Gaseous Multiply Charged Ions by
Fourier-Transform Ion Cyclotron Resonance. J. Am. Soc. Mass
Spectrom. 2001, 12, 245–249.
31. Horn, D. M.; Zubarev, R. A.; McLafferty, F. W. Automated de
Novo Sequencing of Proteins by Tandem High-Resolution
Mass Spectrometry. Proc. Natl. Acad. Sci. U.S.A. 2000, 97,
10313–10317.
32. Horn, D. M.; Ge, Y.; McLafferty, F. W. Activated Ion Electron
Capture Dissociation for Mass Spectral Sequencing of Larger
(42 kDa) Proteins. Anal. Chem. 2000, 72, 4778–4784.
33. Zubarev, R. A.; Horn, D. M.; Fridriksson, E. K.; Kelleher, N. L.;
Kruger, N. A.; Lewis, M. A.; Carpenter, B. K.; McLafferty,
F. W. Electron Capture Dissociation for Structural Character-
ization of Multiply Charged Protein Cations. Anal. Chem. 2000,
72, 563–573.
34. Zubarev, R. A.; Fridriksson, E. K.; Horn, D. M.; Kelleher, N. L.;
Kruger, N. A.; Lewis, M. A.; Carpenter, B. K.; McLafferty,
F. W. Electron Capture Dissociation Produces Many More
Protein Backbone Cleavages than Collisional and IR Excita-
tion. Mass Spectrom. Biol. Med. 2000, 111–120.
35. Schilling, B.; Wang, W.; McMurray, J. S.; Medzihradszky, K. F.
Fragmentation and Sequencing of Cyclic Peptides by Matrix-
Assisted Laser Desorption/Ionization Post-Source Decay
Mass Spectrometry. Rapid Commun. Mass Spectrom. 1999, 13,
2174–2179.
36. Medzihradszky, K. F.; Campbell, J. M.; Baldwin, M. A.; Falick,
A. M.; Juhasz, P.; Vestal, M. L.; Burlingame, A. L. The
Characteristics of Peptide Collision-Induced Dissociation Us-
ing a High-Performance MALDI-TOF/TOF Tandem Mass
Spectrometer. Anal. Chem. 2000, 72, 552–558.
37. Bienvenut, W. V.; Deon, C.; Pasquarello, C.; Campbell, J. M.;
Sanchez, J. C.; Vestal, M. L.; Hochstrasser, D. F. Matrix-
Assisted Laser Desorption/Ionization-Tandem Mass Spectro-
metry with High Resolution and Sensitivity for Identification
and Characterization of Proteins. Proteomics 2002, 2, 868–876.
38. Yergey, A. L.; Coorssen, J. R.; Backlund, P. S. Jr.; Blank, P. S.;
Humphrey, G. A.; Zimmerberg, J.; Campbell, J. M.; Vestal,
M. L. De Novo Sequencing of Peptides Using MALDI/TOF-
TOF. J. Am. Soc. Mass Spectrom. 2002, 13, 784–791.
39. Juhasz, P.; Campbell, J. M.; Vestal, M. L. MALDI-TOF/TOF
Technology for Peptide Sequencing and Protein Identification.
Mass Spectrom. Hyphen. Tech. Neuropeptide Res. 2002, 375–413.
40. Wattenberg, A.; Organ, A. J.; Andrew, J.; Schneider, K.;
Tyldesley, R.; Bordoli, R.; Bateman, R. H. Sequence Dependent
Fragmentation of Peptides Generated by MALDI Quadrupole
Time-of-Flight (MALDI Q-TOF) Mass Spectrometry and Its
Implications for Protein Identification. J. Am. Soc. Mass Spec-
trom. 2002, 13, 772–783.
41. She, Y.-M.; Wang, G.-Q.; Loboda, A.; Ens, W.; Standing, K. G.;
Burczynski, F. J. Sequencing of Rat Liver Cytosolic Proteins by
Matrix-Assisted Laser Desorption Ionization-Quadrupole
Time-of-Flight Mass Spectrometry Following Electrophoretic
Separation and Extraction. Anal. Biochem. 2002, 310, 137–147.
42. She, Y.-M.; Haber, S.; Seifers, D. L.; Loboda, A.; Chernushev-
ich, I.; Perreault, H.; Ens, W.; Standing, K. G. Determination of
the Complete Amino Acid Sequence for the Coat Protein of
Brome Mosaic Virus by Time-of-Flight Mass Spectrometry:
Evidence for Mutations Associated with Change of Propaga-
tion Host. J. Biol. Chem. 2001, 276, 20039–20047.
43. Shevchenko, A.; Sunyaev, S.; Loboda, A.; Shevchenko, A.;
Bork, P.; Ens, W.; Standing, K. G. Charting the Proteomes of
Organisms with Unsequenced Genomes by MALDI-Quadru-
pole Time-of-Flight Mass Spectrometry and BLAST Homology
Searching. Anal. Chem. 2001, 73, 1917–1926.
44. Cramer, R.; Corless, S. The Nature of Collision-Induced Dis-
sociation Processes of Doubly Protonated Peptides: Compar-
ative Study for the Future Use of Matrix-Assisted Laser
Desorption/Ionization on a Hybrid Quadrupole Time-of-
Flight Mass Spectrometer in Proteomics. Rapid Commun. Mass
Spectrom. 2001, 15, 2058–2066.
45. Taylor, J. A.; Johnson, R. S. Implementation and Uses of
Automated de Novo Peptide Sequencing by Tandem Mass
Spectrometry. Anal. Chem. 2001, 73, 2594–2604.
46. Johnson, R. S.; Taylor, J. A. Searching Sequence Databases via
de Novo Peptide Sequencing by Tandem Mass Spectrometry.
Methods Mol. Biol. 2000, 146, 41–61.
47. Hines, W. M.; Falick, A. M.; Burlingame, A. L.; Gibson, B. W.
Pattern-Based Algorithm for Peptide Sequencing from Tan-
dem High Energy Collision-Induced Dissociation Mass Spec-
tra. J. Am. Soc. Mass Spectrom. 1992, 3, 326–336.
48. Fernandez-De-Cossio, J.; Gonzalez, J.; Satomi, Y.; Shima, T.;
Okumura, N.; Besada, V.; Betancourt, L.; Padron, G.; Shimon-
ishi, Y.; Takao, T. Automated Interpretation of Low-Energy
Collision-Induced Dissociation Spectra by SeqMS, a Software
Aid for de Novo Sequencing by Tandem Mass Spectrometry.
Electrophoresis 2000, 21, 1694–1699.
49. Dancik, V.; Addona, T. A.; Clauser, K. R.; Vath, J. E.; Pevzner,
P. A. De Novo Peptide Sequencing via Tandem Mass Spectro-
metry. J. Comput. Biol. 1999, 6, 327–342.
50. Chen, T.; Kao, M.-Y.; Tepel, M.; Rush, J.; Church, G. M. A
Dynamic Programming Approach to de Novo Peptide Se-
quencing via Tandem Mass Spectrometry. J. Comput. Biol.
2001, 8, 325–337.
51. Tabb, D. L.; Smith, L. L.; Breci, L. A.; Wysocki, V. H.; Lin, D.;
Yates, J. R. 3rd. Statistical Characterization of Ion Trap Tan-
dem Mass Spectra from Doubly Charged Tryptic Peptides.
Anal. Chem. 2003, 75, 1155–1163.
52. Loo, J. A.; Edmonds, C. G.; Smith, R. D. Tandem Mass
Spectrometry of Very Large Molecules. 2. Dissociation of
Multiply Charged Proline-Containing Proteins from Electros-
pray Ionization. Anal. Chem. 1993, 65, 425–438.
1020 ZHANG ET AL. J Am Soc Mass Spectrom 2003, 14, 1012–1021
53. Yu, W.; Vath, J. E.; Huberty, M. C.; Martin, S. A. Identification
of the Facile Gas-Phase Cleavage of the Asp-Pro and Asp-Xxx
Peptide Bonds in Matrix-Assisted Laser Desorption Time-of-
Flight Mass Spectrometry. Anal. Chem. 1993, 65, 3015–3023.
54. Qin, J.; Chait, B. T. Preferential Fragmentation of Protonated
Gas-Phase Peptide Ions Adjacent to Acidic Amino Acid Resi-
dues. J. Am. Chem. Soc. 1995, 117, 5411–5412.
55. Tsaprailis, G.; Nair, H.; Somogyi, A.; Wysocki, V. H.; Zhong,
W.; Futrell, J. H.; Summerfield, S. G.; Gaskell, S. J. Influence of
Secondary Structure on the Fragmentation of Protonated
Peptides. J. Am. Chem. Soc. 1999, 121, 5142–5154.
56. Qin, J.; Chait, B. T. Collision-Induced Dissociation of Singly
Charged Peptide Ions in a Matrix-Assisted Laser Desorption
Ionization Ion Trap Mass Spectrometer. Int. J. Mass Spectrom.
1999, 190, 313–320.
57. Cronshaw, J. M.; Krutchinsky, A. N.; Zhang, W.; Chait, B. T.;
Matunis, M. J. Proteomic Analysis of the Mammalian Nuclear
Pore Complex. J. Cell Biol. 2002, 158, 915–927.
58. Zhang, J.; Kalkum, M.; Chait, B. T.; Roeder, R. G. The N-CoR-
HDAC3 Nuclear Receptor Corepressor Complex Inhibits the
JNK Pathway Through the Integral Subunit GPS2. Mol. Cell
2002, 9, 11–623.
59. Krutchinsky, A. N.; Kalkum, M.; Chait, B. T. Automatic
Identification of Proteins with a MALDI-Quadrupole Ion Trap
Mass Spectrometer. Anal. Chem. 2001, 73, 5066–5077.
60. Qin, J.; Fenyo, D.; Zhao, Y.; Hall, W. W.; Chao, D. M.; Wilson,
C. J.; Young, R. A.; Chait, B. T. A Strategy for Rapid, High-
Confidence Protein Identification. Anal. Chem. 1997, 69, 3995–
4001.
61. Krutchinsky, A. N.; Chait, B. T. On the Nature of the Chemical
Noise in MALDI Mass Spectra. J. Am. Soc. Mass Spectrom. 2002,
13, 129–134.
62. Krutchinsky, A. N.; Zhang, W.; Chait, B. T. Rapidly Switch-
able Matrix-Assisted Laser Desorption/Ionization and Elec-
trospray Quadrupole-Time-of-Flight Mass Spectrometry for
Protein Identification. J. Am. Soc. Mass Spectrom. 2000, 11,
493–504.
63. Chait, B. T.; Gisin, B. F.; Field, F. H. Fission Fragment Ioniza-
tion Mass Spectrometry of Alamethicin I. J. Am. Chem. Soc.
1982, 104, 5157–5162.
1021J Am Soc Mass Spectrom 2003, 14, 1012–1021 “DE NOVO” PEPTIDE SEQUENCING BY MALDI
